Emphysema and smoking-related lung diseases

Imaging

Volumn 16, Issue 1, 2004, Pages 50-60

  Screaton, N J ^a   Koh, T ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; CYTOTOXIC AGENT;

ARTICLE; BRONCHIOLITIS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; DESQUAMATIVE PNEUMONIA; DIAGNOSTIC IMAGING; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG CANCER; LUNG EMPHYSEMA; LUNG INJURY; LUNG TRANSPLANTATION; PRIORITY JOURNAL; SMOKING CESSATION; THORAX RADIOGRAPHY;

EID: 33745430017     PISSN: 09656812     EISSN: None     Source Type: Journal    
DOI: 10.1259/imaging/59250435     Document Type: Article

References (85)

1. Britton J, Bates C, Channer K. Tobacco Advisory Group of the Royal College of Physicians. Nicotine addiction in Britain: a report of the tobacco advisory group of the Royal College of Physicians. Vol. 6. Sudbury: The Lavenham Press Ltd, 2000.
2. Pride N, Burrows B. Development of impaired lung function: natural history and risk factors. In: Claverley P, Pride N, editors. Chronic obstructive pulmonary disease. London: Chapman & Hall, 1995:69-91.
3. Deaths from chronic obstructive pulmonary disease in the United States, 1987. AStat Bull Metrop Insur Co, 1990;71:20.
4. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42.
5. Silverman EK, Speizer FE. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 1996;80:501-22.
6. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977;1:1645-8.
7. Bascom R. Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenetics 1991;1:102-6.
8. The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 1985;132:182-5.
9. Adesina AM, et al. Bronchiolar inflammation and fibrosis associated with smoking. A morphologic cross-sectional population analysis. Am Rev Respir Dis 1991;143:144-9.
10. Wallaert B, et al. Inactivation of alpha 1-proteinase inhibitor by alveolar inflammatory cells from smoking patients with or without emphysema. Am Rev Respir Dis 1993;147:1537-43.
11. Saetta M, et al. Extent of centrilobular and panacinar emphysema in smokers' lungs: pathological and mechanical implications. Eur Respir J 1994;7:664-71.
12. Remy-Jardin M, et al. Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests. Radiology 2002;222:261-70.
13. Laws J, Heard B. Emphysema and the chest film: a retrospective radiological and pathological study. Br J Radiol 1962;35:750.
14. Thurlbeck WM, Simon G. Radiographic appearance of the chest in emphysema. AJR Am J Roentgenol 1978;130:429-40.
15. Sutinen S, et al. Roentgenologic criteria for the recognition of nonsymptomatic pulmonary emphysema: correlation between roentgenologic findings and pulmonary pathology. Am Rev Respir Dis 1965;91:69-76.
16. Pratt PC. Role of conventional chest radiography in diagnosis and exclusion of emphysema. Am J Med 1987;82:998-1006.
17. Nicklaus TM, et al. The accuracy of the roentgenologic diagnosis of chronic pulmonary emphysema. Am Rev Respir Dis 1966;93:889-99.
18. Miller RR, et al. Limitations of computed tomography in the assessment of emphysema. Am Rev Respir. Dis 1989;139: 980-3.
19. Bergin CJ, et al. The diagnosis of emphysema: a computed tomographic-pathologic correlation. Am Rev Respir Dis 1986;133:541-6.
20. Thurlbeck WM, Müller NL. Emphysema: definition, imaging, and quantification. AJR Am J Roentgenol 1994;163:1017-25.
21. Spouge D, et al. Panacinar emphysema: CT and pathologic correlation. J Comput Assist Tomogr 1993;17:710-3.
22. Guest PJ, Hansell DM. High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol 1992;45:260-6.
23. King MA, et al. Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996;199:137-41.
24. Gevenois PA, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995;152:653-7.
25. Gevenois PA, et al. Pulmonary emphysema: quantitative CT during expiration. Radiology 1996;199:825-9.
26. Kuwano K, et al. The diagnosis of mild emphysema: correlation of computed tomography and pathology scores. Am Rev Respir Dis 1990;141:169-78.
27. Miller RR, et al. Limitations of computed tomography in the assessment of emphysema. Am Rev Respir Dis 1989;139:980-3.
28. Müller NL, et al. "Density mask": an objective method to quantitate emphysema using computed tomography. Chest 1988;94:782-7.
29. Remy-Jardin M, et al. Sliding thin slab, minimum intensity projection technique in the diagnosis of emphysema: histopathologic-CT correlation. Radiology 1996;200:665-71.
30. Uppaluri R, et al. Quantification of pulmonary emphysema from lung computed tomography images. Am J Respir Crit Care Med 1997;156:248-54.
31. Nagao M, et al. Quantitative analysis of pulmonary emphysema: three-dimensional fractal analysis of single-photon emission computed tomography images obtained with a carbon particle radioaerosol. AJR Am J Roentgenol 1998;171:1657-63.
32. Mishima M, et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci. USA 1999;96:8829-34.
33. Fishman A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-73.
34. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001;345:1075-83.
35. Brenner M, et al. Effects of a novel implantable elastomer device for lung volume reduction surgery in a rabbit model of elastase-induced emphysema. Chest 2002;121:201-9.
36. Ingenito EP, et al. Bronchoscopic volume reduction: a safe and effective alternative to surgical therapy for emphysema. Am J Respir Crit Care Med 2001;164:295-301.
37. Ingenito EP, et al. Bronchoscopic lung volume reduction using tissue engineering principles. Am J Respir Crit Care Med 2003;167:771-8.
38. Toma TP, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361:931-3.
39. Americal Thoracic Society: Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis 1962;85:762.
40. Bates DV, et al. Chronic bronchitis. Report on the third and fourth stages of the co-ordinated study of chronic bronchitis in the Department of Veterans Affairs, Canada. Med Serv J Can 1966;22:1-59.
41. Simon G. Chronic bronchitis and emphysema: a symposium. III. Radiologic changes in chronic bronchitis. Br J Radiol 1959;32:292-4.
42. Simon G, Galbraith HJB. Radiology of chronic bronchitis. Lancet 1953;265:850-2.
43. Fraser RG, et al. The roentgenologic diagnosis of chronic bronchitis: a reassessment with emphasis on parahilar bronchi seen head-on. Radiology 1976;120:1-9.
44. Remy-Jardin M, et al. Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests. Radiology 1993;186:107-15.
45. Nakano Y, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000;162.1102-8.
46. Vassallo R, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003;124: 1199-205.
47. Ryu JH, et al. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001;17:122-32.
48. Nagai S, et al. Smoking-related interstitial lung diseases. Curr Opin Pulm Med 2000;6:415-9.
49. Aubry MC, Wright JL, Myers JL. The pathology of smoking-related lung diseases. Clin Chest Med 2000;21:11-35, vii.
50. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med. 1974;291:755-8.
51. Myers JL, et al. Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 1987;135:880-4.
52. Yousein SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989;64:1373-80.
53. ATS/ERS International Multidisciplinary Consensus Classification of Idiopathic Interstitial Pneumonias: General Principles and Guidelines. American Thoracic Society, Toronto, May 2000.
54. Heyneman LE, et-al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol 1999;173:1617-22.
55. Colby TV. Bronchiolitis. Pathologic considerations. Am J Clin Pathol 1998;109:101-9.
56. Park JS, et al. Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr 2002;26:13-20.
57. Desai SR, Ryan SM, Colby TV. Smoking-related interstitial lung diseases: histopathological and imaging perspectives. Clin Radiol 2003;58:259-68.
58. Carrington CB, et al. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801-9.
59. Hamadeh MA, Atkinson J, Smith LJ. Sulfasalazine-induced pulmonary disease. Chest 1992;101:1033-7.
60. Amir G, Ron N. Pulmonary pathology in Gaucher's disease. Hum Pathol 1999;30:666-70.
61. Gaensler EA, Goff AM, Prowse CM. Desquamative interstitial pneumonia. N Engl J Med 1966;274:113-28.
62. Feigin DS, Friedman PJ, Chest radiography in DIP: a review of 37 patients. AJR Am J Roentgenol 1980;134:91-9.
63. Vedal S, et al. Desquamative interstitial pneumonia: computed tomographic findings before and after treatment with corticosteroids. Chest 1988;93:215-7.
64. Hartman TE, et al. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993; 187:787-90.
65. Hartman TE, et al. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT [see comments). Chest 1996;110:378-82.
66. Akira M, et al. Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 1997;52:333-7.
67. Kambouchner M, et al. Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis. Am J Respir Crit Care Med 2002;166:1483-90.
68. Travis WD, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol 1993;17:971-86.
69. Fartoukh M, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000;161: 216-23.
70. Lacronique J, et al. Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax 1982;37:104-9.
71. Von Essen S, et al. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 1990;98:765-7.
72. Mogulkoc N, et al. Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation. Chest 1999;115:1452-5.
73. Brauner MW, et al. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans [see comments]. Radiology 1997;204:497-502.
74. Tazi A, et al. Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 1998;157:2007-10.
75. Douglas JG, et al. Sarcoidosis: a disorder commoner in non-smokers? Thorax 1986;41:787-91.
76. Johansson S, et al. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol 1998;49:41-7.
77. Weiss W. Cigarette smoking and diffuse pulmonary fibrosis. Am Rev Respir Dis 1969;99:67-72.
78. Auerbach O, et al. Smoking habits and age in relation to pulmonary changes. rupture of alveolar septums, fibrosis and thickening of walls of small arteries and arterioles. N Engl J Med 1963;268:1045-54.
79. Cardoso WV, et al. Collagen and elastin in human pulmonary emphysema. Am Rev Respir Dis 1993;147:975-81.
80. Lang MR, et al. Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax 1994;49:319-26.
81. Baumgartner KB, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997;155:242-8.
82. King TE Jr, et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-81.
83. Douglas WW, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-5.
84. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/ fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47.
85. Hansell D, Nicholson A. Smoking-related diffuse parenchymal lung disease: HRCT-pathological correlation. Sem Resp Crit Care Med 2003;24:377-91.